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Identification and characterization of mammary stem cells and progenitor cells from dairy animals is important in
the understanding of mammogenesis, tissue turnover, lactation persistency and regenerative therapy. It has been
realized by many investigators that altered lactation, long dry periods (non-milking period between two
consecutive lactation cycles), abrupt cessation of lactation (common in water buffaloes) and disease conditions like
mastitis, greatly reduce milk yield thus render huge financial losses within the dairy sector. Cellular manipulation of
specialized cell types within the mammary gland, called mammary stem cells (MaSCs)/progenitor cells, might
provide potential solutions to these problems and may improve milk production. In addition, MaSCs/progenitor
cells could be used in regenerative therapy against tissue damage caused by mastitis. This review discusses
methods of MaSC/progenitor cell manipulation and their mechanisms in bovine and caprine animals. Author
believes that intervention of MaSCs/progenitor cells could lessen the huge financial losses to the dairy industry
globally.
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The ultimate goal of mammary gland and mammary
stem cell biologists in dairy science is to enhance milk
production in lactating dairy animals. Milk production is
affected by the number of secretory cells in the mam-
mary alveolar epithelium and the secretory activity per
cell. The differentiation status of mammary epithelial
cells determines their secretory activity. Poorly differen-
tiated mammary epithelial cells are often non-secretory,
whereas intermediate and fully differentiated cells are
often secretory in nature [1,2]. Classification of these cells
into poor-, intermediate- and fully-differentiated stages,
are based on observation of cellular morphology at high
magnification for the presence of secretory vacuoles, lipid
droplets, nuclear location, cytoplasmic area and cell shape.
Although hormones, like estrogen, progesterone and pro-
lactin influence cytological differentiation of these cells
but their regeneration depends upon the activity of mam-
mary progenitor cells. Mammary progenitor cells are
trans-amplifying cells [3] and are the progeny of mam-
mary stem cells (MaSCs). Reports indicate that MaSCs areCorrespondence: vetdrrkc@gmail.com
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unless otherwise stated.multipotent, giving rise to luminal and basal/myoepitheial
cell types [4,5]. However, a recent report has indicated
MaSCs as lineage-restricted unipotent stem cells in the
mouse [6]. This suggests that re-evaluation of MaSCs is
required to understand the biology of their cell regulation.
For milk-producing dairy animals, more in-depth analysis
of the characterization and regulation of MaSCs and pro-
genitor cells is needed before we can understand how to
influence cell turnover for increased milk production and
tissue homeostasis of the mammary gland. Manipulation
of mammary gland development and milk production
can be achieved using management of photoperiod, fre-
quent milking, machine milking and bovine somato-
trophic (bST) hormone [7,8]. However, manipulation of
MaSCs and progenitor cells for increasing milk produc-
tion is novel and promising, and was first hypothesized by
Capuco et al. [9,10]. This review deals with relatively re-
cent studies performed towards expansion of MaSCs for
determining the impact on milk production. Readers are
encouraged to take note of two recent comprehensive
review articles on MaSCs in animals of veterinary im-
portance, including a comparative study of post-natal
mammary gland development and mammary stem cells
in murine and bovine animals [11,12].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Choudhary Journal of Animal Science and Biotechnology 2014, 5:36 Page 2 of 8
http://www.jasbsci.com/content/5/1/36Review
Mammary stem cells, their identification and
characterization
MaSCs/progenitor cells
MaSCs are multipotent adult stem cells giving rise to cells
of luminal and myoepithelial cell origins. Conventionally,
MaSCs are epithelial in origin. In addition to epithelial
cells, mammary tissue also comprises cells of mesenchymal
origin, including fad pad and connective tissues. Trans-
plantation of dispersed cells into cleared mammary fat pad
and clonal expansion of transplanted cell into functional
mammary gland, have become gold standard methods
to assess the self-renewal property of MaSCs and sup-
port the existence MaSC multipotency [13]. In addition,
researchers have reported MaSCs as bi-potent [14]
and lineage-restricted unipotent stem cells [6]. Indeed,
the precise identification and subsequent characterization
of MaSCs are conflicting [15] and need to be re-evaluated
in the context of their dynamics [16]. Identifying different
MaSC subtypes will allow precise targets to be found for
optimal manipulation of increased milk production.
One of the main roles of adult stem cells is to prolifer-
ate, ensuring organ growth and maintaining tissue homeo-
stasis of the resident organ. During proliferation, stem
cells divide symmetrically and when maintaining tissue
homeostasis, they divide asymmetrically. Symmetrical div-
ision of a stem cell involves mitotic division of the cell into
two daughter stem cells or terminally differentiated cells.
During asymmetrical division, the stem cell produces one
daughter stem cell and one differentiated cell, both cells
possessing dissimilar phenotypes. Although, adult stem
cells have an unlimited proliferation capacity but divide
infrequently in situ. Progenitor cells, the progeny of stem
cells, have a more limited proliferation capacity in com-
parison with stem cells, but divide more frequently.
Lineage restricted progenitor cells have a tremendous pro-
liferation capacity and are responsible for the generation
of differentiated cells to ensure ductal growth, alveolar de-
velopment and ultimately milk production. The regener-
ation capacity of MaSCs is evaluated in vivo using a
transplantation assay in the mammary fat pad of mice that
are devoid of mammary epithelium [17,18]. Likewise, the
regeneration capacity of progenitor cells is tested in vitro
by the colony formation assay [19-21].
Identification of MaSCs/progenitor cells
Various methods for identification of MaSCs have been
performed in different species, as reviewed recently
[22,23]. Among these various methods for enriching the
MaSC population, utilization of cell surface marker
expression is the most common. This method has
been used to successfully identify MaSCs in various
species including human [24,25], murine [18,26] and
bovine [27].BrdU (bromodeoxyuridine) label-retaining epithelial
cells (LRECs) are stem cells identified in various organs,
including murine and bovine mammary glands [28,29].
LRECs do not express estrogen and progesterone recep-
tors (ER− and PR− cells), similar to mammary stem cells
identified by multiparameter cell sorting in mice [30].
Detailed investigation of LRECs from heifer mammary
glands has demonstrated their transcriptome profile that
was harvested from the basal layer (hypothesized loca-
tion of MaSCs) and embedded layer of mammary epithe-
lium layers [31]. Basal layer LRECs were enriched with
stem cell transcripts, and therefore were characteristic of
stem cells. Likewise, LRECs from the embedded layer
were enriched with a few stem cell transcripts, indicative
of progenitor cell characteristics. However, this method
of MaSC and progenitor cell isolation is challenging be-
cause it pushes the limits of research to identify, isolate
and profile the gene signature of the harvested cells. Fur-
thermore, identification of BrdU-LRECs with anti-BrdU
antibody itself is challenging because anti-BrdU antibody
only binds with BrdU antigens when the DNA is single
stranded. To expose BrdU antigens in mammary cryo-
sections, antigen retrieval using harsh chemicals, like al-
kali, acids or heat, is imperative. This likely destroys the
morphology of the cells, as well as their nucleic acids and
proteins. Additionally, the heat generated using a laser
beam for microdissection will degrade RNA quality of tis-
sue sections on glass slides [32,33]. The scant amount
of nucleic acid isolated from microdissected cells was
barely sufficient to perform global gene expression ana-
lysis. A novel method that permits the identification of
BrdU-LRECs without compromising RNA quality [34] is
reported for the laser microdissection of LRECs and non-
LRECs (control cells) to enable transcriptome profiling of
bovine MaSCs and progenitor cells [31]. Unfortunately,
this method does not permit in vitro or in vivo analysis of
the microdissected cells because the cells apoptose during
harvesting. Interestingly, this method does permit study of
the stem cell niche, because the cells are harvested from
specific in situ locations.
Characterization of bovine and caprine MaSCs/progenitor
cells
Several studies have been performed to identify bovine
MaSCs and progenitor cells. Initial investigations were
based on staining and morphological characteristics,
namely the intensity of staining, size and shape of the
cell and nucleus, nucleus to cytoplasmic ratio, and pres-
ence of cell organelles. Light stained cells were suggest-
ive of MaSCs, which were pleomorphic and occurred
singularly or in pairs [35]. Paired light stained cells were
suggestive of the proliferation potential of these cells,
which was later confirmed by Ki-67 expression. In pre-
pubertal bovine mammary glands, approximately 10% of
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were proliferating (Ki-67 positive).
Multiparameter cell sorting using a cocktail of anti-
bodies appeared to be the most common method to
identify MaSCs and progenitor cells in human, mice and
bovine tissues. Expression of cluster of differentiation
(CD) molecules, like CD24 (heat stable antigen) and
CD49f (integrin alpha 6) on Lin- sorted cells, revealed
features of bovine MaSCs (CD24med, CD49fpos), basal
bipotent progenitors (CD24neg, CD49fpos), luminal uni-
potent progenitors (CD24high, CD49fneg), and luminal
unipotent cells (CD24med, CD49fneg) [27].
Stem cell antigen 1 (Sca-1) appears to be a controversial
marker for MaSCs. Sca-1 is a glycosyl phosphatidylinositol
(GPI)-anchored cell surface protein present in the lipid
raft of the cell membrane and regulates many signaling
events [36]. For identification of putative bovine MaSCs in
one study, Sca-1 sorted cells appeared to be located in the
stroma and elicited hematopoietic transcriptomic charac-
teristics [37]. However, MaSCs are epithelial in origin and
should be localized within the epithelial compartment of
the bovine mammary gland. A combination of Sca-1
marker with a panel of existing MaSC markers should en-
able an enriched stem cell population to be distinguished
with respect to the unipotent, bipotent and truly differen-
tiated cells. A recent study of murine mammary glands in-
dicated that the differential gene expression profile of
sorted and non-sorted cells using Sca-1, CD24 and CD49f,
identified two types of luminal cells (Sca-1pos and Sca-1neg
cells, both CD24high), basal cells (Sca1neg CD24low
CD49fhigh) and myoepithelial cells (Sca1neg CD24low
CD49flow) [26]. Basal cells with high CD49f expression
were considered as putative MaSCs located in the basal
layer.
Although fluorescent activated cell sorting (FACS) can
be used to identify MaSCs and progenitor cells in vari-
ous species, it has failed to provide information about
the stem cell niche. This is because the preparation of a
single cell suspension of mammary tissue involves en-
zymatic digestion of tissues and therefore disrupts all
cellular and extracellular attachment of prospective stem
cells. An alternative approach, BrdU-label retention
method, successfully identified LRECs as enriched popu-
lation of MaSC and progenitor cells [31]. LRECs had low
expression of estrogen receptor (ESR1) and high expres-
sion of aldehyde dehydrogenase 3B1 (ALDH3B1) in the
basal LRECs. Higher expression of nuclear receptor sub-
family 5, group A, member 2 (NR5A2), a pluripotency
transcription factor [38] and little to no expression of
XIST, X-chromosome inactivation factor [39] in basal
LREC is consistent with stem cell characteristics [31]. In
the same study, embedded LRECs appeared to be more
committed progenitor cells, evidenced by down-regulation
of cell survival and proliferation factors IGF2, HSPB6,NR5A2, and nestin. Nestin is a mammary stem cells
marker [40].
The discovery of pluripotency factors, including OCT4,
SOX2 and NANOG, as new markers for MaSCs is novel
[41,42]. Furthermore, the presence of MaSCs in milk and
the fact that milk is a cheap and non-invasive source of
MaSCs is of considerable interest [43]. However, use of
pluripotency factors as additional markers of MaSC and
progenitor cells remains to be validated. Understanding
MaSC plasticity and the interactions between stem cells,
progenitor cells, differentiated cells and stroma, is import-
ant to comprehend their biology and regulation within
the gland. This will allow for the development of an ef-
fective strategy for improving milk production and live-
stock management.
The first demonstration of different cell types within
goat mammary tissue reported the existence of luminal
and myoepithelial cells [44], which were based on ex-
pression of cytokeratins (CK). Further, analyses sug-
gested there were certain cells that were undifferentiated
(observed by loss of CK expression) which remained in
the alveoli of the lactating goat mammary gland. These
undifferentiated cells with loss of CK, including the lu-
minal epithelial cell differentiation marker, CK18, which
indicated the presence of mammary stem or progenitor
cells in the goat mammary tissue. Convincingly, the pres-
ence of caprine MaSCs and progenitor cells was demon-
strated based upon in vivo transplantation of sorted cells
in NOD/SCID mice and in vitro by the colony formation
assay [14].
Methods of MaSCs/progenitor cell expansion
The idea of MaSC expansion to increase cell turn over,
enhance tissue regeneration and secretory activity of
mammary epithelial cells was proposed by Capuco et al.
[10,45,46]. During early postnatal life, increased activity
of MaSCs and progenitor cells is responsible for ductal
growth [46,47], which later during established lactation
declines [10,48]. Stem and progenitor cells have three
different fates; 1) they divide symmetrically and increase
their numbers, 2) they divide asymmetrically and maintain
their numbers and 3) they differentiate into terminally
differentiated cells and die via programmed cell death or
apoptosis (Figure 1). Endogenous factors, including the
estrogen, progesterone and growth hormones, as well
as exogenous compounds including bST, xanthosine and
inosine, have been shown to expand MaSC and progenitor
cell numbers and mammary epithelial cell populations
[7,9,49-53]. It appears that these factors and compounds
affect cell kinetics and enhance proliferation (Figure 2).
Another instance that influences the rate of stem and
progenitor cell activity is the dynamics of mammary gland
physiology. An increased progenitor cell population during
pregnancy indicates a role of progesterone in influencing
Figure 1 Mammary stem cells/progenitor cells have three basic
cellular division fates depending upon the physiological stage
of the animal. 1) Expansion occurs when cells divide symmetrically
to produce two daughter stem cells of similar potency; 2) Maintenance
occurs when cells divide asymmetrically and produce one
daughter stem/progenitor cell and one differentiated cell that
may later undergo apoptosis; 3) Expansion occurs when cells divide
symmetrically, but exhaust in the case of terminal differentiation which
produces two differentiated cells, both of which may later undergo
apoptosis; 4) Cells exhaust when they undergo apoptosis.
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(pregnancy associated) progenitor cells, also termed ‘parity
induced MaSCs (PI-MaSCs) are reported to be located in
the terminal duct of the alveolar unit, and are thought to
originate from cells that skipped apoptosis during the lastFigure 2 Increased proliferation of MaSCs can increase the progenitor ce
can ultimately lead to increased numbers of mammary epithelial cells. These chpregnancy [54]. The presence of PI-MaSCs has been con-
firmed in multiparous mice (absent in nulliparous) as
multipotent stem cells by a transplantation study [55].
However, this was later refuted by generation of a mam-
mosphere from tissue explants obtained from nulliparous
mice [56]. Multiparous animals have a greater number of
PI-MaSCs in the luminal epithelium than nulliparous
mice [57], which is consistent with the previous study
[58]. This suggests that expression of novel markers of bo-
vine MaSCs and progenitor cells, including NUP153,
NR5A2 and HNF4A [31], were significantly increased in
multiparous lactating animals (peak lactation) than in
nulliparous (heifer) animals. This is consistent with the
idea that multiparous animals have greater numbers of PI-
MaSCs than nulliparous animals. However, it remains
unknown whether MaSCs and PI-MaSCs are similar or
different.Taken together, these studies indicate that the
physiology of the animals affects the number and activity
of MaSCs/progenitor cells.
Use of nucleosides xanthosine and inosine
Xanthosine and inosine are purine nucleosides that act as
precursors of de novo biosynthesis of guanine ribonucleo-
tide. Sherley and colleagues [59,60] demonstrated that p53
mediates asymmetric division of rat hepatic stem cells and
hair follicle stem cells. This action is mediated via down-
regulation of inosine-5′-monophosphate dehydrogenase
(IMPDH), the rate-limiting enzyme for guanine ribonucle-
otide synthesis. Addition of xanthosine or inosine into
the system circumvents the IMPDH-mediated step and
thus increases guanine concentration in the cell, thereby
promoting symmetric division of stem cells and theirll population. Unlimited but high proliferation capacity of progenitor cells
anges in turn lead to increased secretion of milk and repair tissue damage.
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to increase stem cells, including LRECs, within the mam-
mary gland of heifers in vivo [9]. Capuco and colleagues
[52] further provided evidence that xanthosine increases
mammary epithelial cell proliferation and the putative
stem cell population in primary cultures of lactating bo-
vine mammary epithelial cells. Details of the transcrip-
tomic changes induced by xanthosine and the molecular
mechanisms of how xanthosine alters cell proliferation,
awaits further elucidation.
Use of growth hormone and estrogen
The scarcity of MaSCs and a universal marker to identify
their pure population has hampered their study. Investi-
gators have realized that during puberty, there is ductal
growth of the mammary tree in the presence of estrogen
and growth hormone. Therefore, estrogen and growth
hormone might be responsible for the proliferation of
MaSCs/progenitor cells present in the ducts [61]. Growth
of Sca-1pos cells in the presence of estrogen and growth
hormone resulted in a greater number of Sca-1pos cells in
culture, evidenced by growth of the mammospheres and
differentiation potential [62]. This study suggests that
MaSC and progenitor cell populations could be increased
when cells are grown in the presence of estrogen and
growth hormone.
Use of progesterone and progestin
Progesterone is a hormone, which maintains pregnancy
of the animal. One study provided the evidence of nat-
ural progesterone triggers mammary alveologenesis and
expansion of MaSCs (CD24posCD49fhigh) in mice [49],
which was consistent with the finding that progesterone
increases DNA replication and progenitor cell population
in the breast [63]. These studies indicate that progesterone
certainly has a role in the regulation of MaSCs/progenitor
cells. In the mammary system, progesterone acts on MaSCs
in a paracrine fashion [64]. Immunohistochemical analysis
of bovine mammary tissue revealed PR expression in the
nuclei of mammary epithelial cells, stromal and endothelial
cells in heifers and lactating animals [65]. Mammary epithe-
lial cells of the basal layer, the hypothesized location of
MaSCs, usually lacks PR expression [28,65]. WNT4 and
RANKL pathways mediate the mitogenic effect of proges-
terone [49,66]. Increased expression of RANKL in luminal
cells and RANK (the receptor of RANKL) in basal cells,
are the likely effectors of progesterone in basal MaSCs.
Progesterone in combination with estrogen resulted in
higher cell proliferation in the mammary gland than estro-
gen alone [67].
Xanthosine, inosine and lactation persistency
Xanthosine has been shown to increase mammary epi-
thelial cell proliferation [9,52]. Changes in mammaryepithelial cell dynamics during lactation affects milk pro-
duction. For instance, increased secretory activity of the
epithelium is reported to be responsible for increased
milk production from early lactation to peak lactation in
cows. However a decline in milk production from peak
lactation to late lactation is due to a decline in epithelial
cell number [7]. Although secretory activity per cell did
not change significantly from peak to late lactation, the
number of secretory cells declined due to increased
apoptosis in non-pregnant cows, which was responsible
for the declining milk production. In pregnant and lac-
tating cows, the effect of declining milk production was
more pronounced owing to concomitant demands of
nutrients for pregnancy and lactation. A reduction in
milk yield was evident in continuously milked dairy cows
[68-71], unlike that of goats where continuous milking did
not adversely affect milk production [2,72]. In goats, con-
tinuously milked glands had a greater number of fully dif-
ferentiated cells (maximum secretory activity per cell) but
with fewer alveoli and thus a reduced number of mam-
mary epithelial cells [2]. The rate of proliferation and epi-
thelial cell differentiation also varies depending on the
parity of animals. Primiparous goats are more persistent
owing to higher cell proliferation and cell survival after
parturition than multiparous animals [73]. If xanthosine
increases mammary epithelial cell proliferation, than it
would diminish cell apoptosis during late lactation. A
diminished rate of cell apoptosis during late lactation
will likely lead to increased availability of secretory cells
(flatten the milking curve), thereby maintaining the
milk production for an extended period. In other words,
xanthosine treatment could be used to extend persistency
of lactation.
Inosine, a compound similar to xanthosine, has been
successfully used to increase milk production in trans-
genic goats [51]. Transgenic goats are poor milk producers
owing to accelerated cell death [74] and intramammary ad-
ministration of inosine during early lactation has been
shown to increase milk production from day one to peak
lactation period (50 days). This study was based on the ex-
periment that demonstrated xanthosine increased MaSCs
and progenitor cells in heifers [9]. This study further tested
the hypothesis that stimulating MaSCs using inosine could
induce the cascade of cell proliferation in transgenic goats
and prevent premature cessation of lactation. Clearly, the
study indicates the role of inosine in increasing MaSC
numbers in transgenic goats. It has been well- documented
that increased concentration of guanine ribonucleotides in
stem cells favor symmetric mitotic cell division [53]. An
increased number of epithelial cells, due to increased
MaSCs, could have resulted increased secretory cells. An
increased number of mammary secretory cells have pro-
duced more milk for extended time. It is imperative here
to validate this result, that inosine really, increases MaSC
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osine administration to goats and other dairy animals need
to be evaluated.
Management of the dry period to ensure more milk
production during next lactation
The non-lactating period between two consecutive lacta-
tion cycles is called the dry period. The dry period is
critical to regenerate mammary epithelial cells. It is the
time to replace the senescent cells that have lost produc-
tion ability, with new epithelial cells that can be used to
produce milk during next lactation. It can be hypothesize
that during the dry period, progenitor cell activity is high
which is responsible for increased cell turn over. Usually
animals during the dry period are pregnant and therefore
influenced by progesterone hormone, because hormone
maintains pregnancy. Progesterone harbingers the mam-
mogenic effects that are manifested by increased cell
turnover and MaSC/progenitor cell activity. Usually, the
length of the dry period in the cow is 50–60 days. A re-
duction in the non-productive dry period length is indir-
ectly associated with increased milk production due to the
reduced time of the non-productive period. At the end of
the dry period lactation starts. Lactation cycle is divided
into various stages- early, peak and late stage- depending
upon the amount of milk produced by the animals. Main-
taining the peak stage of milk production longer than
average milk production is called persistency of lactation
and such animals are called persistent. These persistent
animals are less exposed to calving-related stress and low
milk production potential during the initial lactation cycle.
Apart from this, reducing the length of the dry period
from 60 to 30 days could be another approach to increase
the efficiency of lactation. It has been shown that a short-
ened dry period (30 days) or omitted dry period in the
presence of bST hormone, did not alter milk production
of multiparous cows during the next lactation [70]. This
result was consistent with the finding that administration
of bST in lactating Holstein cow increased mammary epi-
thelial cell renewal, as evidenced by a 3-fold increase in
expression of the proliferation marker, Ki-67, in bST-
treated animal compared with control animals [7]. In
other words, a 60-day dry period could be reduced to 30-
day for regeneration of mammary epithelium without
deleterious effect on milk production in next lactation.
Conclusions and future directions
This review describes manipulation methods of MaSCs/
progenitor cells that could influence future milk produc-
tion, mainly in dairy animals. Emphasis has been given
to cows and goat mammary glands with some imperative
missing information supplemented from mice. Prolifera-
tion of both MaSCs and progenitor cells with natural
hormonal treatments like progesterone, estrogen andgrowth hormone, and by exogenous administration of
xanthosine or inosine, could potentially increase milk
production of dairy animals by increasing cell turnover
or persistency of lactation. Further investigations are es-
sential to understand the biology of MaSCs/progenitor
cells and their role in mammary gland morphogenesis,
tissue turnover and homeostasis. Recent reports of the
existence of MaSCs in breast milk and pluripotency fac-
tors as additional markers of MaSC [43], raises many
questions like whether MaSCs possess multi-lineage po-
tential. Why MaSCs are present in the milk? Does MaSCs
have any role in infants who drink mother’s milk? It would
also be useful to determine whether these pluripotency
transcription factors are involved in the self-renewal of
MaSC? Use of milk as a non-invasive source of MaSCs for
their identification and characterization is a novel and
promising.
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